Focus:
Servier Pharmaceuticals is constructing Servier Paris-Saclay research institute, a new research and development hub in the Paris-Saclay cluster, France, which is one of the world’s...
Vaccine Manufacturing Innovation Centre (VMIC) in Oxfordshire will become the first-ever facility dedicated to the...
Read More...
Vetter, a contract development and manufacturing organisation (CDMO) based in the US, is expanding its...
Read More...
Virginia Cancer Specialists (VCS) opened a phase I clinical research facility in Fairfax, Northern Virginia,...
Read More...
Leading global contract development and manufacturing organisation (CDMO) Vetter began construction of its new production...
Read More...
Massachusetts-based biotechnology company Vertex Pharmaceuticals (Vertex) is currently relocating its headquarters from Cambridge to Fan...
Read More...
Alpha Biologics, a contract biomanufacturing service provider, commissioned a new cGMP biomanufacturing plant in April
Read More...
Vivalis opened a new R&D facility in Saint-Herblain, Nantes, France on 28 June 2010. The...
Read More...
The Van Andel Institute completed a $178m phase II expansion on its cancer research facility...
Read More...
Vetter Pharma's new small-scale fill-finish facility is in Skokie, a suburb of Chicago. Located at...
Read More...
Velesco Pharmaceutical is a provider of analytical procedure development, drug formulation, stability testing and consul
Read More...
